Skip to main contentSkip to navigation
Sirius Investors
HBM Holdings Limited

HBM Holdings Limited

HBMHF
OTCHealthcare

HBM Holdings Limited (HBMHF) Investment Research Dashboard

About HBM Holdings Limited (HBMHF) stock analysis

Get live HBMHF stock price $2.52, comprehensive HBM Holdings Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time HBMHF stock data and investment insights.

2.52
61.54%Today
Market Cap
2.10B
Volume
600
52W High
2.54
52W Low
1.56

Loading chart data...

HBM Holdings Limited (HBMHF) Overview

HBM Holdings Limited (HBMHF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, HBMHF trades at $2.52 with a market capitalization of 2.10B . Over the past 52 weeks, HBMHF has traded between $1.56 and $2.54 , with the current price positioned at approximately 98% of this range . The stock currently trades at...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 2.10B
  • Current price: $2.52
  • 52-week range: $1.56 - $2.54
  • P/E ratio: 27.03

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

HBM Holdings Limited is a biopharmaceutical company in the clinical development phase, dedicated to the discovery and advancement of differentiated antibody therapeutics for immunological and oncological disorders. The firm's robust pipeline includes...

Company Information

CEO
Jingsong Wang
Sector
Healthcare
Industry
Biotechnology
Employees
272

Contact Information

Address
Tower A, 12th Floor
Country
CN

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 27.0)

Higher growth potential with elevated volatility (Beta: 1.33)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for HBM Holdings Limited shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for HBM Holdings Limited
  • Investors should consider how HBM Holdings Limited fits within their overall portfolio allocation

Market Cap

2.10B

P/E Ratio (TTM)

27.03

Beta

1.33

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare HBMHF with peer companies:

Acumen Pharmaceuticals, Inc. (ABOS)
Price
$2.28+3.64% (1D)
Market cap
164.68M
Acurx Pharmaceuticals, Inc. (ACXP)
Price
$1.41-1.40% (1D)
Market cap
2.23M
Anebulo Pharmaceuticals, Inc. (ANEB)
Price
$0.33+0.00% (1D)
Market cap
13.46M
Bio-Path Holdings, Inc. (BPTH)
Price
$0.04+5.26% (1D)
Market cap
373.69K
Cingulate Inc. (CING)
Price
$4.53+0.22% (1D)
Market cap
25.40M
Day One Biopharmaceuticals, Inc. (DAWN)
Price
$21.53+0.00% (1D)
Market cap
2.22B
Eliem Therapeutics, Inc. (ELYM)
Price
$5.11+0.00% (1D)
Market cap
342.68M
Endonovo Therapeutics, Inc. (ENDV)
Price
$0.00+0.00% (1D)
Market cap
31.88K
Entera Bio Ltd. (ENTX)
Price
$3.26-16.84% (1D)
Market cap
160.69M
HCW Biologics Inc. (HCWB)
Price
$2.59-2.45% (1D)
Market cap
898.65K
Inozyme Pharma, Inc. (INZY)
Price
$4.00+0.00% (1D)
Market cap
258.25M
MediciNova, Inc. (MNOV)
Price
$1.33+0.76% (1D)
Market cap
65.46M
Molecular Partners AG (MOLN)
Price
$3.83-4.36% (1D)
Market cap
143.68M
NextCure, Inc. (NXTC)
Price
$5.42+5.86% (1D)
Market cap
19.58M
Purple Biotech Ltd. (PPBT)
Price
$1.37-4.86% (1D)
Market cap
189.18K
Rezolute, Inc. (RZLT)
Price
$4.92-0.40% (1D)
Market cap
473.76M
Sio Gene Therapies Inc. (SIOX)
Price
$0.48+0.00% (1D)
Market cap
N/A
Soleno Therapeutics, Inc. (SLNO)
Price
$53.01+0.00% (1D)
Market cap
2.76B
TRACON Pharmaceuticals, Inc. (TCON)
Price
$0.03+0.00% (1D)
Market cap
109.72K
VectivBio Holding AG (VECT)
Price
$16.87+0.00% (1D)
Market cap
1.06B
Vincerx Pharma, Inc. (VINC)
Price
$0.01+0.00% (1D)
Market cap
66.47K
Virpax Pharmaceuticals, Inc. (VRPX)
Price
$0.00-75.00% (1D)
Market cap
124
X4 Pharmaceuticals, Inc. (XFOR)
Price
$3.93-0.25% (1D)
Market cap
370.68M
XOMA Royalty Corp. (XOMA)
Price
$40.17+0.00% (1D)
Market cap
503.77M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

80/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+5.7%+6.1%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%+3.3%+3.5%24.1
80/100⭐⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
56/100⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
56/100⭐⭐⭐⭐
Real Estate-0.5%-0.1%-1.6%29.2
43/100⭐⭐⭐
Energy-2.1%-5.8%-5.1%19.1
39/100⭐⭐
Utilities-1.0%-3.0%-5.9%26.8
28/100⭐⭐
Industrials+0.6%+1.7%-11.2%30.1
26/100⭐⭐
Consumer Cyclical+0.5%-0.4%-6.3%43.0
21/100
Technology+0.6%-2.3%-9.6%40.7
17/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.